Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V J Hruby

Showing results (341-350 of 504) with videos related to

Pageof 51
Sort By:
Journal of Medicinal Chemistry|January 7, 1994
Design of cyclic deltorphins and dermenkephalins with a disulfide bridge leads to analogues with high selectivity for delta-opioid receptorsA Misicka, A W Lipkowski, R Horvath, et al.
Biochimica Et Biophysica Acta|August 17, 1984
Metabolic effects and cyclic AMP levels produced by glucagon, (1-N alpha-Trinitrophenylhistidine,12-homoarginine)glucagon and forskolin in isolated rat hepatocytesS Corvera, J Huerta-Bahena, J T Pelton, et al.
Proceedings of the Western Pharmacology Society|January 1, 1991
Antinociceptive and gastrointestinal transit effects of cholecystokinin (CCK-8) and related analogs of CCK-8 in the mouseE A Ayres, D N Parkhurst, S Fang, et al.
Life Sciences|January 1, 1996
Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical studyR T Dorr, R Lines, N Levine, et al.
Life Sciences|January 1, 1989
A high affinity, highly selective ligand for the delta opioid receptor: [3H]-[D-Pen2, pCl-Phe4, d-Pen5]enkephalinL K Vaughn, R J Knapp, G Toth, et al.
The Journal of Investigative Dermatology|April 1, 1990
In vitro transdermal delivery of a melanotropic peptide through human skinB V Dawson, M E Hadley, N Levine, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1987
Pharmacologic evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitroJ E Shook, J T Pelton, W S Wire, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 1, 1997
Antipyretic role of endogenous melanocortins mediated by central melanocortin receptors during endotoxin-induced feverQ H Huang, M L Entwistle, J D Alvaro, et al.
Journal of Medicinal Chemistry|June 19, 1998
Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase: conformational and topographical constraints in peptide designJ Alfaro-Lopez, W Yuan, B C Phan, et al.
Journal of Medicinal Chemistry|August 15, 1997
beta-Methylation of the Phe7 and Trp9 melanotropin side chain pharmacophores affects ligand-receptor interactions and prolonged biological activityC Haskell-Luevano, K Toth, L Boteju, et al.
Pageof 51

Showing results (341-350 of 504) with videos related to

Sort By:
Pageof 51
Journal of Medicinal Chemistry|January 7, 1994
Design of cyclic deltorphins and dermenkephalins with a disulfide bridge leads to analogues with high selectivity for delta-opioid receptorsA Misicka, A W Lipkowski, R Horvath, et al.
Biochimica Et Biophysica Acta|August 17, 1984
Metabolic effects and cyclic AMP levels produced by glucagon, (1-N alpha-Trinitrophenylhistidine,12-homoarginine)glucagon and forskolin in isolated rat hepatocytesS Corvera, J Huerta-Bahena, J T Pelton, et al.
Proceedings of the Western Pharmacology Society|January 1, 1991
Antinociceptive and gastrointestinal transit effects of cholecystokinin (CCK-8) and related analogs of CCK-8 in the mouseE A Ayres, D N Parkhurst, S Fang, et al.
Life Sciences|January 1, 1996
Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical studyR T Dorr, R Lines, N Levine, et al.
Life Sciences|January 1, 1989
A high affinity, highly selective ligand for the delta opioid receptor: [3H]-[D-Pen2, pCl-Phe4, d-Pen5]enkephalinL K Vaughn, R J Knapp, G Toth, et al.
The Journal of Investigative Dermatology|April 1, 1990
In vitro transdermal delivery of a melanotropic peptide through human skinB V Dawson, M E Hadley, N Levine, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1987
Pharmacologic evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitroJ E Shook, J T Pelton, W S Wire, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 1, 1997
Antipyretic role of endogenous melanocortins mediated by central melanocortin receptors during endotoxin-induced feverQ H Huang, M L Entwistle, J D Alvaro, et al.
Journal of Medicinal Chemistry|June 19, 1998
Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase: conformational and topographical constraints in peptide designJ Alfaro-Lopez, W Yuan, B C Phan, et al.
Journal of Medicinal Chemistry|August 15, 1997
beta-Methylation of the Phe7 and Trp9 melanotropin side chain pharmacophores affects ligand-receptor interactions and prolonged biological activityC Haskell-Luevano, K Toth, L Boteju, et al.
Pageof 51